Braveheart Bio, Inc. (BRVE)
17.28
-0.14
(-0.78%)
USD |
NASDAQ |
Nov 06, 10:25
Braveheart Bio Net Income (Quarterly) : -14.99M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.99M |
| March 31, 2026 | -14.28M |
| Date | Value |
|---|---|
| June 30, 2025 | -0.381M |
| March 31, 2025 | -0.099M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.162B |
| Trulieve Cannabis Corp. | -405.36M |
| Journey Medical Corp. | -0.312M |
| Turn Therapeutics, Inc. | -5.850M |
| ANI Pharmaceuticals, Inc. | 23.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.99M |
| EPS Diluted (Quarterly) | -0.2066 |
| Enterprise Value | 1.659B |
| Earnings Yield | -2.14% |
| Normalized Earnings Yield | -2.135 |